Status:
UNKNOWN
Value of Uric Acid as Early Predictor of Lupus Nephritis
Lead Sponsor:
Assiut University
Conditions:
Uric Acid
Eligibility:
All Genders
18-75 years
Brief Summary
The aim of the present work is to determine the role of uric acid as a predictor and prognostic factor in the development of lupus nephritis.
Detailed Description
Systemic Lupus Erythematosus (SLE) is a systemic autoimmune disorder identified by the production of autoantibodies and immune complex deposition \[1\]. It presents with a variety of unpredictable fla...
Eligibility Criteria
Inclusion
- All patients fulfilled the European League Against Rheumatism (EULAR) and the American college of rheumatology (ACR)
Exclusion
- Exclusion criteria were the use of diuretics, aspirin, cyclosporine, or any drugs affect level of uric acid Also exlude patients with hypertension, diabetes , dyslipidemia and obesity
Key Trial Info
Start Date :
June 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 25 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05402735
Start Date
June 15 2022
End Date
August 25 2023
Last Update
June 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
assuit University
Asyut, Egypt